Statin Use and the Risk of Proliferative Vitreoretinopathy in Eyes Undergoing Rhegmatogenous Retinal Detachment...

Area of Science:

• Ophthalmology
• Retinal Surgery
• Pharmacology

Background:

• Rhegmatogenous retinal detachment (RRD) repair is a common ophthalmic surgical procedure.
• Proliferative vitreoretinopathy (PVR) is a significant complication following RRD repair, often necessitating reoperation.
• The role of systemic medications in modulating PVR risk is an area of ongoing research.

Purpose of the Study:

• To investigate the association between statin medication use and the incidence of PVR.
• To determine if statin use impacts the rate of return to the operating room after primary RRD repair.

Main Methods:

• A retrospective analysis of 54,876 eyes undergoing RRD repair from January 2015 to November 2024.
• Patient data was sourced from the Vestrum Health Retina Database.
• Multivariate regression analysis was employed to adjust for potential confounding factors.

Main Results:

• Statin use (n=17,922) was associated with a lower frequency of PVR development within 90 days post-RRD repair compared to non-statin users (6.67% vs. 8.17%, P < .001).
• Multivariate analysis confirmed that statin use independently decreased the likelihood of PVR (OR: 0.70, 95% CI: 0.66-0.75).

Conclusions:

• Statin use is linked to a reduced risk of PVR formation after RRD repair.
• The findings suggest a potential protective effect of statins in preventing PVR and the need for reoperation in RRD patients.